Browse Category

NASDAQ:SMR News 21 January 2026

NuScale Power stock whipsaws after BlackRock filing as investors scan fresh SMR economics study

NuScale Power stock whipsaws after BlackRock filing as investors scan fresh SMR economics study

New York, January 21, 2026, 12:46 ET — Regular session NuScale Power shares fell 2.5% to $18.52 on Wednesday, after earlier climbing as high as $21.08. The nuclear technology developer saw a sharp reversal on heavy volume during the session. BlackRock revealed it owns 9.73 million NuScale Class A shares—about 3.4% of the company—in an amended Schedule 13G filing dated…

Stock Market Today

  • Delcath Systems Grants Equity Awards to New Hires Under Nasdaq Rule
    January 21, 2026, 4:41 PM EST. Delcath Systems, Inc. (Nasdaq: DCTH), a firm specializing in liver cancer treatments, announced on January 21, 2026, inducement grants totaling 36,250 Restricted Stock Units (RSUs) to four employees hired late 2025. These RSUs vest over three years and comply with Nasdaq Listing Rule 5635(c)(4). The awards stem from Delcath's 2023 Inducement Plan, tying compensation to ongoing employment. Delcath's proprietary HEPZATO KIT, FDA-approved in the U.S., delivers high-dose chemotherapy directly to the liver, minimizing systemic exposure. The company's focus on metastatic uveal melanoma addresses a critical niche in oncology, enhancing its market profile. The stock-based incentives reflect strategic talent acquisition efforts amid evolving therapeutic advancements in interventional oncology.
Go toTop